Patent details

EP3328887 Title: ANTI-GM-CSF ANTIBODIES AND USES THEREOF

Basic Information

Publication number:
EP3328887
PCT Application Number:
CN2017102057
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP178405460
PCT Publication Number:
WO2018050111
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-GM-CSF ANTIBODIES AND USES THEREOF
French Title of Invention:
ANTICORPS ANTI-GM-CSF ET LEURS UTILISATIONS
German Title of Invention:
ANTI-GM-CSF-ANTIKÖRPER UND VERWENDUNGEN DAFÜR
SPC Number:

Dates

Filing date:
18/09/2017
Grant date:
18/08/2021
EP Publication Date:
06/06/2018
PCT Publication Date:
22/03/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/08/2021
EP B1 Publication Date:
18/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/09/2021
Expiration date:
18/09/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/08/2021
 
 

Name:
I-Mab Biopharma (Hangzhou) Co., Ltd.
Address:
6F, No.3 Bld., Hexiang Technology Center, Qiantang New Area Hangzhou Zhejiang, China (CN)

Inventor

1

Name:
WANG, Zhengyi
Address:
China (CN)

2

Name:
GUO, Bingshi
Address:
China (CN)

3

Name:
ZANG, Jingwu
Address:
China (CN)

4

Name:
FANG, Lei
Address:
China (CN)

Priority

1

Priority Number:
201610832677
Priority Date:
19/09/2016
Priority Country:
China (CN)

2

Priority Number:
201610831525
Priority Date:
19/09/2016
Priority Country:
China (CN)

Classification

IPC classification:
A61K 39/00; C07K 16/24; A61P 37/06; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202133
Publication date:
18/08/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages